Literature DB >> 24778180

Haptoglobin genotype-dependent differences in macrophage lysosomal oxidative injury.

Rabea Asleh1, John Ward2, Nina S Levy2, Shady Safuri2, Doron Aronson3, Andrew P Levy2.   

Abstract

The major function of the Haptoglobin (Hp) protein is to control trafficking of extracorpuscular hemoglobin (Hb) thru the macrophage CD163 receptor with degradation of the Hb in the lysosome. There is a common copy number polymorphism in the Hp gene (Hp 2 allele) that has been associated with a severalfold increased incidence of atherothrombosis in multiple longitudinal studies. Increased plaque oxidation and apoptotic markers have been observed in Hp 2-2 atherosclerotic plaques, but the mechanism responsible for this finding has not been determined. We proposed that the increased oxidative injury in Hp 2-2 plaques is due to an impaired processing of Hp 2-2-Hb complexes within macrophage lysosomes, thereby resulting in redox active iron accumulation, lysosomal membrane oxidative injury, and macrophage apoptosis. We sought to test this hypothesis in vitro using purified Hp-Hb complex and cells genetically manipulated to express CD163. CD163-mediated endocytosis and lysosomal degradation of Hp-Hb were decreased for Hp 2-2-Hb complexes. Confocal microscopy using lysotropic pH indicator dyes demonstrated that uptake of Hp 2-2-Hb complexes disrupted the lysosomal pH gradient. Cellular fractionation studies of lysosomes isolated from macrophages incubated with Hp 2-2-Hb complexes demonstrated increased lysosomal membrane oxidation and a loss of lysosomal membrane integrity leading to lysosomal enzyme leakage into the cytoplasm. Additionally, markers of apoptosis, DNA fragmentation, and active caspase 3 were increased in macrophages that had endocytosed Hp 2-2-Hb complexes. These data provide novel mechanistic insights into how the Hp genotype regulates lysosomal oxidative stress within macrophages after receptor-mediated endocytosis of Hb.
© 2014 by The American Society for Biochemistry and Molecular Biology, Inc.

Entities:  

Keywords:  Apoptosis; Atherosclerosis; Genetic Polymorphism; Hemoglobin; Lysosome; Macrophage; Oxidative Stress; α-Tocopherol

Mesh:

Substances:

Year:  2014        PMID: 24778180      PMCID: PMC4047400          DOI: 10.1074/jbc.M114.554212

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  55 in total

1.  Haptoglobin phenotype and vascular complications in patients with diabetes.

Authors:  A P Levy; A Roguin; I Hochberg; P Herer; S Marsh; F M Nakhoul; K Skorecki
Journal:  N Engl J Med       Date:  2000-09-28       Impact factor: 91.245

Review 2.  Redox activity within the lysosomal compartment: implications for aging and apoptosis.

Authors:  Tino Kurz; John W Eaton; Ulf T Brunk
Journal:  Antioxid Redox Signal       Date:  2010-08-15       Impact factor: 8.401

3.  Lipofuscin-bound iron is a major intracellular source of oxidants: role in senescent cells.

Authors:  Annika Höhn; Tobias Jung; Stefanie Grimm; Tilman Grune
Journal:  Free Radic Biol Med       Date:  2010-01-29       Impact factor: 7.376

4.  Increased expression of oxidation-specific epitopes and apoptosis are associated with haptoglobin genotype: possible implications for plaque progression in human atherosclerosis.

Authors:  K-Raman Purushothaman; Meerarani Purushothaman; Andrew P Levy; Patrick A Lento; Solene Evrard; Jason C Kovacic; Karen C Briley-Saebo; Sotirios Tsimikas; Joseph L Witztum; Prakash Krishnan; Annapoorna Kini; Zahi A Fayad; Valentin Fuster; Samin K Sharma; Pedro R Moreno
Journal:  J Am Coll Cardiol       Date:  2012-07-10       Impact factor: 24.094

5.  Vitamin E reduces cardiovascular disease in individuals with diabetes mellitus and the haptoglobin 2-2 genotype.

Authors:  Shany Blum; Moshe Vardi; Jonathan B Brown; Allen Russell; Uzi Milman; Chen Shapira; Nina S Levy; Rachel Miller-Lotan; Rabea Asleh; Andrew P Levy
Journal:  Pharmacogenomics       Date:  2010-05       Impact factor: 2.533

6.  The haptoglobin 2-2 genotype is associated with increased redox active hemoglobin derived iron in the atherosclerotic plaque.

Authors:  Shiri Kalet-Litman; Pedro R Moreno; Andrew P Levy
Journal:  Atherosclerosis       Date:  2009-09-06       Impact factor: 5.162

Review 7.  Receptor targeting of hemoglobin mediated by the haptoglobins: roles beyond heme scavenging.

Authors:  Marianne Jensby Nielsen; Søren Kragh Moestrup
Journal:  Blood       Date:  2009-04-20       Impact factor: 22.113

8.  Cathepsin L is significantly associated with apoptosis and plaque destabilization in human atherosclerosis.

Authors:  Wei Li; Louise Kornmark; Lena Jonasson; Claes Forssell; Xi-Ming Yuan
Journal:  Atherosclerosis       Date:  2008-04-18       Impact factor: 5.162

9.  Haptoglobin phenotype and prevalent coronary heart disease in the Framingham offspring cohort.

Authors:  Andrew P Levy; Martin G Larson; Diane Corey; Rachel Lotan; Joseph A Vita; Emelia J Benjamin
Journal:  Atherosclerosis       Date:  2004-02       Impact factor: 5.162

Review 10.  Macrophage apoptosis in atherosclerosis: consequences on plaque progression and the role of endoplasmic reticulum stress.

Authors:  Ira Tabas
Journal:  Antioxid Redox Signal       Date:  2009-09       Impact factor: 8.401

View more
  9 in total

1.  Identification of a protein associated with the activity of cytokine-induced killer cells.

Authors:  Jingsong Cao; Cong Chen; Yongqiang Gao; Li Hu; Yu Liang; Jianhua Xiao
Journal:  Oncol Lett       Date:  2017-09-25       Impact factor: 2.967

2.  Pharmacogenomic interaction between the Haptoglobin genotype and vitamin E on atherosclerotic plaque progression and stability.

Authors:  Hilla-Lee Veiner; Rostic Gorbatov; Moshe Vardi; Gheorghe Doros; Rachel Miller-Lotan; Yaniv Zohar; Edmond Sabo; Rabea Asleh; Nina S Levy; Levi J Goldfarb; Thomas A Berk; Tali Haas; Hadar Shalom; Edith Suss-Toby; Adi Kam; Marielle Kaplan; Ronit Tamir; Anna Ziskind; Andrew P Levy
Journal:  Atherosclerosis       Date:  2015-01-14       Impact factor: 5.162

3.  Modeling hemoglobin and hemoglobin:haptoglobin complex clearance in a non-rodent species-pharmacokinetic and therapeutic implications.

Authors:  Felicitas S Boretti; Jin Hyen Baek; Andre F Palmer; Dominik J Schaer; Paul W Buehler
Journal:  Front Physiol       Date:  2014-10-09       Impact factor: 4.566

4.  Meta-analysis of the association of the haptoglobin genotype with cardiovascular outcomes and the pharmacogenomic interactions with vitamin E supplementation.

Authors:  Rabea Asleh; Alexandros Briasoulis; Elliot M Berinstein; Joshua B Wiener; Mohan Palla; Sudhir S Kushwaha; Andrew P Levy
Journal:  Pharmgenomics Pers Med       Date:  2018-04-23

5.  Haptoglobin Genotype Is a Determinant of Hemoglobin Adducts and Vitamin E Content in HDL.

Authors:  Hagit Goldenstein; Nina S Levy; John Ward; Tina Costacou; Andrew P Levy
Journal:  J Diabetes Res       Date:  2018-05-20       Impact factor: 4.011

Review 6.  Hemolysis Derived Products Toxicity and Endothelium: Model of the Second Hit.

Authors:  Marie Frimat; Idris Boudhabhay; Lubka T Roumenina
Journal:  Toxins (Basel)       Date:  2019-11-13       Impact factor: 4.546

7.  Haptoglobin: an emerging candidate for phenotypic modulation of sickle cell anemia?

Authors:  Magnun Nueldo Nunes Dos Santos
Journal:  Rev Bras Hematol Hemoter       Date:  2015-10-09

8.  Haptoglobin 2-2 Phenotype Is Associated With Increased Acute Kidney Injury After Elective Cardiac Surgery in Patients With Diabetes Mellitus.

Authors:  Chenzhuo Feng; Bhiken I Naik; Wenjun Xin; Jennie Z Ma; David C Scalzo; Swapna Thammishetti; Robert H Thiele; Zhiyi Zuo; Jacob Raphael
Journal:  J Am Heart Assoc       Date:  2017-10-05       Impact factor: 5.501

9.  Single cell analysis of M. tuberculosis phenotype and macrophage lineages in the infected lung.

Authors:  Davide Pisu; Lu Huang; Vipin Narang; Monique Theriault; Gabrielle Lê-Bury; Bernett Lee; Agnes E Lakudzala; David T Mzinza; David V Mhango; Steven C Mitini-Nkhoma; Kondwani C Jambo; Amit Singhal; Henry C Mwandumba; David G Russell
Journal:  J Exp Med       Date:  2021-07-22       Impact factor: 14.307

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.